|
|
News Breaks | | | | September 25, 2012 | | 06:20 EDT |  | GEVO | Gevo downgraded to Hold from Buy at ThinkEquity
ThinkEquity downgraded Gevo following yesterday's announcement it would halt production of isobutanol at its first commercial scale facility in Luverne, MN. Price target lowered to $3 from $8. | |
|
News For GEVO From The Last 14 Days Check below for free stories on GEVO the last two weeks. |
|
|
| May 10, 2013 | | 10:15 EDT |  | GEVO | Gevo confirms temporary dismissal of lawsuit against Butamax, DuPont
 Subscribe for More Information | | | 09:06 EDT | | GEVO | Court dismisses all claims in Gevo case against Butamax
Butamax Advanced Biofuels announced that the United States District Court for Delaware has issued an order dismissing the action that Gevo asserted against Butamax in relation to United States Patent No. 8,101,808. Gevo has indicated that the '808 patent claims cover Gevo's GIFT technology for the removal of isobutanol, the technology used at Gevo's Luverne plant prior to its shut down last year. Butamax is moving ahead with the first phase of a plant retrofit this year. A hallmark of Butamax's development progress is the grant of 7 patents in 2013 alone, including an entirely new method for recovery of bioisobutanol from fermentation | |
|
|
|
|
|
|
